Larimar Therapeutics posts updated investor presentation; no financial results disclosed

Larimar Therapeutics, Inc.

Company posted an updated slide presentation on its website on August 14, 2023 for use in investor meetings.
No new financial guidance, clinical data, or material business developments were disclosed in the 8-K.
The presentation is filed as Exhibit 99.1 but its full content is not available in the provided text.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.